Phase II Study of TS-1 with Patient-Reported Outcome(PRO) Evaluation in Elderly Patients with Advanced NSCLC
Phase 2
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000002035
- Lead Sponsor
- Department of Respiratory Medicine & Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)History of severe allergy 2)Received surgery or radiotherapy to primary region 3)Use of other clinical trial drugs or phenytoin warfarin or flucytosine 4)Serious infection,SIADH,vena cava superior syndrome 5)Serious medical complications 6)Massive pleural effusion,ascites and penicardial effusion requires drainage 7)Symptomatic brain metastasis 8)Require radiotherapy to primary region 9)Concomitant malignancy 10)Intention to be pregnant in the future 11)Other clinical difficulties to this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method